- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Adlai Nortye Ltd ADR (ANL)
Assess today's live Adlai Nortye Ltd ADR (ANL) share price, performance and insights using our live NASDAQ: ANL stock exchange data.
Analyse the historical data and Adlai Nortye Ltd ADR share price performance charts on this page. Our technical summary section provides analysis on Adlai Nortye ADR share price buy/sell indicators using real-time data (or discuss the Adlai Nortye ADR (ANL) stock price today with other investors in the Adlai Nortye ADR NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ ANL share price (ISIN: US00704R1095) to enhance your trading decisions with our free investment tools and resources.
What Is the Adlai Nortye Ltd ADR Share Price Today?
The Adlai Nortye ADR share price today is 1.52.
What Is the Stock Symbol for Adlai Nortye Ltd ADR
The stock symbol (or 'ticker') for Adlai Nortye Ltd ADR is "ANL."
What Stock Exchange Does Adlai Nortye Ltd ADR Trade On?
Adlai Nortye Ltd ADR is listed and trades on the NASDAQ stock exchange.
Is Adlai Nortye Ltd ADR a Good Stock to Buy?
Determining whether Adlai Nortye Ltd ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Adlai Nortye Ltd ADR share price performance charts on this page. Our technical summary section provides analysis on Adlai Nortye ADR share price buy/sell indicators using real-time data (or discuss the Adlai Nortye ADR (ANL) stock price today with other investors in the Adlai Nortye ADR NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ ANL share price (ISIN: US00704R1095) to enhance your trading decisions with our free investment tools and resources.
What Is the Adlai Nortye Ltd ADR Share Price Today?
The Adlai Nortye ADR share price today is 1.52.
What Is the Stock Symbol for Adlai Nortye Ltd ADR
The stock symbol (or 'ticker') for Adlai Nortye Ltd ADR is "ANL."
What Stock Exchange Does Adlai Nortye Ltd ADR Trade On?
Adlai Nortye Ltd ADR is listed and trades on the NASDAQ stock exchange.
Is Adlai Nortye Ltd ADR a Good Stock to Buy?
Determining whether Adlai Nortye Ltd ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
1.52
-0.01(-0.65%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.41
1.61
52 wk Range
0.88
2.99
ANL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.411.61
52 wk Range
0.882.99
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ANL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Neutral
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Neutral
Adlai Nortye ADR Company Profile
Adlai Nortye Ltd., a clinical-stage biotechnology company, engages in the research and development of pharmaceutical products. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trials for the treatment of recurrent or metastatic head and neck squamous cell carcinomas. The company is also developing AN0025, a small molecule prostaglandin E receptor 4 antagonist to modulate the tumor microenvironment that is in a Phase Ib clinical trial for the treatment of recurrent non-small cell lung cancer and urothelial cancer after anti-PD-1/PD-L1 treatments, recurrent triple-negative breast cancer, microsatellite stable colorectal cancer, and cervical cancer after standard of care treatments; and AN4005, an oral small-molecule PD-L1 inhibitor, which is in Phase I clinical trials to induce and stabilize PD-L1 dimerization and disrupt the interaction between PD-1 and PD-L1. Its preclinical candidates include AN8025, a multifunctional antibody as T cell and antigen-presenting cell modulator; and AN9025, an oral small molecule pan-KRAS inhibitor. The company was founded in 2004 and is based in Grand Cayman, the Cayman Islands.
Compare ANL to Peers and Sector
Metrics to compare | ANL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipANLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.1x | −6.1x | −0.6x | |
PEG Ratio | −0.01 | 0.08 | 0.00 | |
Price/Book | 2.2x | 3.0x | 2.6x | |
Price / LTM Sales | - | 520.9x | 3.2x | |
Upside (Analyst Target) | - | 146.8% | 41.8% | |
Fair Value Upside | Unlock | 0.9% | 5.1% | Unlock |
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 0.00
Earnings
Latest Release
Dec 03, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Adlai Nortye ADR (ANL) Share Price Today?
The live Adlai Nortye ADR share price today is 1.52
What Stock Exchange Does Adlai Nortye ADR (ANL) Trade On?
Adlai Nortye ADR is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Adlai Nortye ADR?
The stock symbol (also called a 'ticker') for Adlai Nortye ADR is "ANL."
What Is the Current Adlai Nortye ADR Market Cap?
As of today, Adlai Nortye ADR market capitalisation is 56.09M.
What Is Adlai Nortye ADR's (ANL) Earnings Per Share (TTM)?
The Adlai Nortye ADR EPS is currently -1.62 (Trailing Twelve Months).
When Is the Next Adlai Nortye ADR Earnings Date?
Adlai Nortye ADR's next earnings report will be released on 25 Feb 2026.
Is ANL a Buy or Sell From a Technical Analyst Perspective?
Based on today's Adlai Nortye ADR moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Adlai Nortye ADR Stock Split?
Adlai Nortye ADR has split 0 times. (See the ANL stock split history page for full effective split date and price information.)
How Many Employees Does Adlai Nortye ADR Have?
Adlai Nortye ADR has 123 employees.
What is the current trading status of Adlai Nortye ADR (ANL)?
As of 24 Dec 2025, Adlai Nortye ADR (ANL) is trading at a price of 1.52, with a previous close of 1.52. The stock has fluctuated within a day range of 1.41 to 1.61, while its 52-week range spans from 0.88 to 2.99.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.